Your request to link to rcsb for BDBM50393740


  • 4F09: discovery and optimization of c-2 methyl imidazo-pyrrolopyridines as potent and orally bioavailable jak1 inhibitors with selectivity over jak2 (10.1021/JM300628C )
  • 4EHZ: the jak1 kinase domain in complex with inhibitor (10.1021/JM300628C )